EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›OVTZ

OVTZ

OCULUS INC.

Next earnings Aug 6, 2026

Hold
$0.03
▼ -6.00%
$0.03▼ -29.50%
over 1Y
L $0.02EODHDH $0.04
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-6.0%
1W+0.0%
1M+0.0%
3M+0.0%
YTD+0.0%
1Y-25.0%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
D
Valuation
Fair value
Filings
Clean
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 9 analysts
Buy

High return on equity (43.3%).

Revenue (FY2019) $0.00 · FY2019

OCULUS INC. shows $0.00 in FY2019 revenue, and 43.3% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue—————
Gross profit—————
Operating income-$1.99M-$2.07M———
Net income-$1.99M-$1.65M-$591K-$327K-$319K
Diluted EPS-$0.02————
Net margin—————

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$2.57M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-12.4%
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt—
Net cash$9.41K
Piotroski F-Score4/7

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. 10-Q Quarterly report2026-05-12
  2. 10-K Annual report2026-03-20
  3. 10-Q Quarterly report2025-11-12
  4. 8-K Shareholder vote2025-10-16
  5. DEF 14A Proxy statement2025-08-28
  6. 10-Q Quarterly report2025-08-08
  7. 10-Q Quarterly report2025-05-12
  8. 10-K Annual report2025-03-20
  9. 8-K Charter / bylaws change2025-01-14

Recent filings

all on EDGAR ↗
10-QPeriod ending 2026-03-312026-05-12open ↗10-KPeriod ending 2025-12-312026-03-20open ↗10-QPeriod ending 2025-09-302025-11-12open ↗ARSPeriod ending 2024-12-312025-11-12open ↗DEFA14AFiling2025-11-12open ↗8-KPeriod ending 2025-10-152025-10-16open ↗DEF 14APeriod ending 2025-10-152025-08-28open ↗PRE 14APeriod ending 2025-10-152025-08-12open ↗10-QPeriod ending 2025-06-302025-08-08open ↗10-QPeriod ending 2025-03-312025-05-12open ↗10-KPeriod ending 2024-12-312025-03-20open ↗8-KPeriod ending 2024-12-262025-01-14open ↗

Quality score

D
ValueGrowthProfitHealthMom.
Value—
GrowthC+
Profitability—
Financial healthF
Momentum—
  • ✗Profitable (positive net income)
Revenue
$0.00
Net margin
—
ROE
—
P/E
—

SEC fundamentals · FY 2025

■ revenue · ■ net income, by fiscal year

Revenue$0.00
Net income-$319K+2.5%
Operating income-$2.07M-4.1%
Diluted EPS-$0.02+50.0%
Cash & equivalents$9.41K-19.7%
Total assets$32.2K-18.6%
Stockholders' equity-$738K-80.2%

Frequently asked

Is OCULUS INC. (OVTZ) a buy?
OVTZ currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. High return on equity (43.3%).
What is OCULUS INC.'s quality score?
OVTZ scores 40.49999999999999/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001107280, latest 10-Q filed 2026-05-12) · EODHD · as of 6/23/2026, 12:09:45 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2021-04-19
DRESCHER ANTON J
Chief Financial Officer (CFO)
Buy100K @ $0.80$80.0K

Recent news

market news →
Palmer Luckey Says Apple's New CEO John Ternus May Have Built Early VR Gear He Used As A Teen: 'His Only Non-Apple Job Was...'Bullish
finance.yahoo.com· 2026-04-28
Meta Layoffs: Is the Facebook Parent Getting Ready for Another "Year of Efficiency"?Bullish
finance.yahoo.com· 2026-04-24
Well, there goes the metaverse!Bullish
finance.yahoo.com· 2026-01-19
Bridgewater, D.E. Shaw among top hedge fund gainers of 2025Bullish
finance.yahoo.com· 2026-01-02
Bridgewater, D.E. Shaw Among Top Hedge Fund Gainers of 2025Bullish
finance.yahoo.com· 2026-01-02
Oculus Founder Palmer Luckey's 'Lord Of The Rings'-Inspired Digital Bank Hits $2 Billion Valuation With Backing From Founders FundBullish
finance.yahoo.com· 2025-07-19

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score40 vs 67
Revenue growth— vs 7.1%
Net margin— vs 10.5%
Return on equity— vs 12.3%
P/E— vs 25.5